← Back to Patent Explorer
US4851331A Expired / Lapsed US ⏱️ 0.0 years remaining

Method and kit for polynucleotide assay including primer-dependant DNA polymerase

Assignee: Honeywell International Inc
•
Filing: 1986-05-16
•
Granted: 1989-07-25
•
Expires: 2006-05-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A probe polynucleotide binds to a target nucleotide sequence in the nucleic acid of a biological sample, and then is enzymatically extended in the 3'-direction with a mixture of nucleoside triphosphates including at least one nucleoside triphosphate that has been detectably labeled. After separating extended hybrid from unreacted nucleoside triphosphates, detectably-modified nucleotides which have been incorporated are determined. In some forms, the 3'-terminal nucleotide of the probe polynucleotide is selected to form a matched pair with some sample strands, but a mismatched pair with other sample strands. In such cases, if the primer dependent enzyme used for extension is one lacking 3'-exonuclease activity, then only those hybrids forming such a matched pair will be extended and subsequently determined.

Inventors

  • 👤 Calvin P. H. Vary
  • 👤 Steven E. Diamond

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 03:37
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6844; C12Q1/6858; C12Q1/6813; C12Q1/6869; Y; Y10; Y10S; Y10S435/00; Y10S435/81

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 173 words
A method for the determination of a target nucleotide sequence in the nucleic acid of a biological sample which comprises the steps: (a) contacting a biological sample having a target nucleotide sequence unseparated from plural non-target polynucleotide sequences with a probe polynucleotide strand under conditions sufficient for the probe polynucleotide to bind only to the target nucleotide sequence to form a hybrid having a double-stranded portion including the 3' end of the probe polynucleotide, with the target nucleic acid sequence extending in a 3' to 5' direction beyond the 3' end nucleotide of the probe polynucleotide; (b) extending the probe polynucleotide strand of the hybrid beyond its 3' end in the 5' to 3' direction by using the target nucleic acid strand as a template strand and incorporating nucleoside triphosphates from solution, a plurality of the nucleotides incorporated into the extended probe strand being detectably-modified nucleotides; and (c) determining the amount of detectably-modified nucleotides which have been incorporated into probe polynucleotide strand as a measure of target nucleotide sequence in the biological sample.
Claim 2
Independent Claim 173 words
A method for the determination of a target nucleotide sequence in the nucleic acid of a biological sample which comprises the steps: (a) contacting a biological sample having a target nucleotide sequence unseparated from plural non-target polynucleotide sequences with a probe polynucleotide strand under conditions sufficient for the probe polynucleotide to bind only to the target nucleotide sequence to form a hybrid having a double-stranded portion including the 3' end of the probe polynucleotide, with the target nucleic acid sequence extending in a 3' to 5' direction beyond the 3' end nucleotide of the probe polynucleotide; (b) extending the probe polynucleotide strand of the hybrid beyond its 3' end in the 5' to 3' direction by using the target nucleic acid strand as a template strand and incorporating nucleoside triphosphates from solution, a plurality of the nucleotides incorporated into the extended probe strand being detectably-modified nucleotides; and (c) determining the amount of detectably-modified nucleotides which have been incorporated into probe polynucleotide strand as a measure of target nucleotide sequence in the biological sample.
Claim 3
Dependent Claim 14 words
The method of claim 1 wherein the contacting step (a) is performed in solution.
Claim 4
Dependent Claim 14 words
The method of claim 2 wherein the extending step (b) is performed in solution.
Claim 5
Dependent Claim 24 words
The method of claim 3 further comprising, after the extending step (b), separating from unincorporated nucleoside triphosphates polynucleotides including the extended probe polynucleotide strand.
Claim 6
Dependent Claim 36 words
The method of claim 4 wherein the separating step comprises immobilizing polynucleotides, including the hybrid of extended probe polynucleotide strand with target polynucleotide, onto a solid support and washing from the solid support unincorporated nucleoside triphosphates.
Claim 7
Dependent Claim 16 words
The method of claim 5 wherein the detecting step (c) is performed on the solid support.
Claim 8
Dependent Claim 48 words
The method of claim 6 wherein the detectably-modified nucleotides include an affinity moiety, and wherein the detecting step (c) comprises: (c1) contacting the solid support with a conjugate of a label and an affinity reagent of the affinity moiety, and (c2) detecting label adhering to the solid support.
Claim 9
Dependent Claim 35 words
The method of claim 5 wherein the probe polynucleotide contains an affinity moiety, and wherein the solid support contains an affinity reagent for the affinity moiety to specifically immobilize polynucleotides which contain the probe polynucleotide.
Claim 10
Dependent Claim 53 words
The method of claim 1 wherein the non-target nucleotide sequences are capable of binding to the probe polynucleotide during the contacting step (a) to form a mismatched hybrid including a mismatched base pair at the 3'-terminal nucleotide of the probe polynucleotide, and wherein mismatched hybrids are not extended during the extending step (b).
Claim 11
Dependent Claim 23 words
The method of claim 9 wherein the extending step (b) is performed with a primer-dependent DNA polymerase having substantially no 3' exonuclease activity.
Claim 12
Dependent Claim 22 words
The method of claim 10 wherein the target nucleotide sequence is RNA and wherein the primer-dependant DNA polymerase is a reverse transcriptase.
Claim 13
Dependent Claim 14 words
The method of claim 10 wherein the primer-dependent DNA polymerase is a reverse transcriptase.
Claim 14
Dependent Claim 12 words
The method of claim 10 wherein the target nucleotide sequence is DNA.
Claim 15
Dependent Claim 14 words
The method of claim 13 wherein the primer-dependent DNA polymerase is of eukaryotic origin.
Claim 16
Dependent Claim 25 words
The method of claim 1 wherein the biological sample comprises intact cells or tissue, and wherein hybrids form in situ during the contacting step (a).
Claim 17
Dependent Claim 14 words
The method of claim 15 wherein the having target nucleotide sequence is single-stranded RNA.
Claim 18
Dependent Claim 31 words
The method of claim 15 wherein the having target nucleotide sequence is double-stranded sample DNA and wherein, prior to or during the contacting step (a), the double-stranded sample DNA is denatured.
Claim 19
Dependent Claim 19 words
The method of claim 17 wherein the double-stranded sample DNA is heat denatured in the presence of probe polynucleotide.
Claim 20
Dependent Claim 31 words
The method of claim 1 wherein the having target nucleotide sequence is double-stranded sample DNA and wherein, prior to or during the contacting step (a), the double-stranded sample DNA is denatured.
Claim 21
Dependent Claim 19 words
The method of claim 19 wherein the double-stranded sample DNA is heat denatured in the presence of probe polynucleotide.
Claim 22
Dependent Claim 144 words
A kit for the determination of a target nucleotide sequence in the nucleic acid of a biological sample comprising: (a) a probe polynucleotide comprising a primer sequence substantially complementary to target and non-target nucleotide sequences in a biological sample, wherein said target nucleotide sequence contains a nucleotide complementary to the 3'-terminal nucleotide of said probe to form a template for primer-dependent nucleic acid polymerase and wherein said non-target nucleotide sequences contain nucleotides not complementary to said 3'-terminal nucleotide of said probe; (b) a plurality of nucleoside triphosphates, wherein at least one of said nucleoside triphosphates is modified to contain a detectable label; and (c) a primer-dependent nucleic acid polymerase which is substantially free of exonuclease activity, wherein said polymerase extends primers in a 5' to 3' direction when the 3'-terminal nucleotide of the primer is complementary to a nucleotide on a template polynucleotide sequence.
Claim 23
Dependent Claim 144 words
A kit for the determination of a target nucleotide sequence in the nucleic acid of a biological sample comprising: (a) a probe polynucleotide comprising a primer sequence substantially complementary to target and non-target nucleotide sequences in a biological sample, wherein said target nucleotide sequence contains a nucleotide complementary to the 3'-terminal nucleotide of said probe to form a template for primer-dependent nucleic acid polymerase and wherein said non-target nucleotide sequences contain nucleotides not complementary to said 3'-terminal nucleotide of said probe; (b) a plurality of nucleoside triphosphates, wherein at least one of said nucleoside triphosphates is modified to contain a detectable label; and (c) a primer-dependent nucleic acid polymerase which is substantially free of exonuclease activity, wherein said polymerase extends primers in a 5' to 3' direction when the 3'-terminal nucleotide of the primer is complementary to a nucleotide on a template polynucleotide sequence.
Claim 24
Dependent Claim 15 words
The kit of claim 21 wherein the primer-dependant nucleic acid polymerase is a reverse transcriptase.
Claim 25
Dependent Claim 19 words
The kit of claim 21 wherein the primer-dependant nucleic acid polymerase is a primer-dependant DNA polymerase of eukaryotic origin.
Claim 26
Dependent Claim 14 words
The kit of claim 21 wherein said modified nucleoside triphosphate is biotin-modified deoxyuridine triphosphate.

References Cited (Backward Citations)

EP0063879A2 Cited
WO1984002702A1 Cited
EP0123513A1 Cited
US4683202A Cited
US4683202B1 Cited
US4683195A Cited
US4683195B1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-07-24 1993-01-23 1993-07-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-07-24 1997-01-23 1997-07-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-07-24 2001-01-23 2001-07-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag